Save your place

Sign in to WhoBought

Please try again later.

Celldex Therapeutics, Inc. (CLDX) institutional ownership

Latest close $34.77 Jul 22, 2026
Market cap$1.5B 52-week range SectorHealthcare
Funds holding · Q1 2026
193
reported CLDX position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
121 buyers · 72 sellers

Celldex Therapeutics, Inc. (CLDX) price and institutional activity

Dates

Q1 2026

$0 bought by 121 investors
Point72 Asset Management, L.P.Wellington Management Group LLP +119 more
$0 sold by 72 investors
Bellevue Group AGFMR LLC +70 more
Bought Sold Totals per quarter; hover a bar for the names.

Celldex Therapeutics, Inc. (CLDX) institutional activity · 193

Investor Type Est. change Change Δ Own Date
Bellevue Group AG · Reduced
Change −2.4M Date Q1 2026
Bellevue Group AG Reduced· Q1 2026 −2.4M Q1 2026
Point72 Asset Management, L.P. · Added
Change +1.5M Δ Own +83.7% Date Q1 2026
Point72 Asset Management, L.P. Added· Q1 2026 +1.5M +83.7% Q1 2026
FMR LLC · Reduced
Change −1.2M Δ Own −23.6% Date Q1 2026
FMR LLC Reduced· Q1 2026 −1.2M −23.6% Q1 2026
Polar Capital Holdings PLC · Exited
Change −1.0M Δ Own −100.0% Date Q1 2026
Polar Capital Holdings PLC Exited· Q1 2026 −1.0M −100.0% Q1 2026
Deep Track Capital, LP · Reduced
Change −617K Date Q1 2026
Deep Track Capital, LP Reduced· Q1 2026 −617K Q1 2026
Eventide Asset Management, LLC · Reduced
Change −606K Date Q1 2026
Eventide Asset Management, LLC Reduced· Q1 2026 −606K Q1 2026
State Street · Reduced
Change −594K Date Q1 2026
State Street Reduced· Q1 2026 −594K Q1 2026
Braidwell LP · Reduced
Change −502K Date Q1 2026
Braidwell LP Reduced· Q1 2026 −502K Q1 2026
Wellington Management Group LLP · Added
Change +481K Δ Own +6.0% Date Q1 2026
Wellington Management Group LLP Added· Q1 2026 +481K +6.0% Q1 2026
Ikarian Capital, LLC · New
Change +461K Date Q1 2026
Ikarian Capital, LLC New· Q1 2026 +461K Q1 2026
Dimensional · Added
Change +408K Date Q1 2026
Dimensional Added· Q1 2026 +408K Q1 2026
Eversept Partners, LP · Added
Change +353K Date Q1 2026
Eversept Partners, LP Added· Q1 2026 +353K Q1 2026
Kennedy Capital Management LLC · New
Change +352K Date Q1 2026
Kennedy Capital Management LLC New· Q1 2026 +352K Q1 2026
Rosalind Advisors, Inc. · New
Change +330K Date Q1 2026
Rosalind Advisors, Inc. New· Q1 2026 +330K Q1 2026
Foresite Capital Management VI LLC · New
Change +316K Date Q1 2026
Foresite Capital Management VI LLC New· Q1 2026 +316K Q1 2026
Data through Q1 2026 · filed Jun 4, 2026
15 of 193

Famous investor activity in Celldex Therapeutics, Inc. (CLDX)

Celldex Therapeutics, Inc. (CLDX) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Lawver Teri L. · Officer Grant (A) 90K
Owned 90K Trade date Jun 25, 2026 Filed date Jun 29, 2026
Lawver Teri L. Officer Grant (A) 90K 90K Jun 25, 2026 Jun 29, 2026
Jimenez Freddy A. · Officer Grant (A) 93K
Owned 93K Trade date Jun 25, 2026 Filed date Jun 29, 2026
Jimenez Freddy A. Officer Grant (A) 93K 93K Jun 25, 2026 Jun 29, 2026
Young Diane C. · Officer Grant (A) 57K
Owned 57K Trade date Jun 25, 2026 Filed date Jun 29, 2026
Young Diane C. Officer Grant (A) 57K 57K Jun 25, 2026 Jun 29, 2026
Heath-Chiozzi Margo · Officer Grant (A) 95K
Owned 95K Trade date Jun 25, 2026 Filed date Jun 29, 2026
Heath-Chiozzi Margo Officer Grant (A) 95K 95K Jun 25, 2026 Jun 29, 2026
Martin Samuel Bates · Officer Grant (A) 93K
Owned 93K Trade date Jun 25, 2026 Filed date Jun 29, 2026
Martin Samuel Bates Officer Grant (A) 93K 93K Jun 25, 2026 Jun 29, 2026
Cavanaugh Sarah · Officer Grant (A) 95K
Owned 95K Trade date Jun 25, 2026 Filed date Jun 29, 2026
Cavanaugh Sarah Officer Grant (A) 95K 95K Jun 25, 2026 Jun 29, 2026
Crowley Elizabeth · Officer Grant (A) 100K
Owned 100K Trade date Jun 25, 2026 Filed date Jun 29, 2026
Crowley Elizabeth Officer Grant (A) 100K 100K Jun 25, 2026 Jun 29, 2026
Pepin Ronald · Officer Grant (A) 20K
Owned 20K Trade date Jun 25, 2026 Filed date Jun 29, 2026
Pepin Ronald Officer Grant (A) 20K 20K Jun 25, 2026 Jun 29, 2026
Keler Tibor · Officer Grant (A) 115K
Owned 115K Trade date Jun 25, 2026 Filed date Jun 29, 2026
Keler Tibor Officer Grant (A) 115K 115K Jun 25, 2026 Jun 29, 2026
Marucci Anthony S. · Director Grant (A) 375K
Owned 375K Trade date Jun 25, 2026 Filed date Jun 29, 2026
Marucci Anthony S. Director Grant (A) 375K 375K Jun 25, 2026 Jun 29, 2026
Torres Denice · Director Grant (A) 26K
Owned 26K Trade date Jun 25, 2026 Filed date Jun 29, 2026
Torres Denice Director Grant (A) 26K 26K Jun 25, 2026 Jun 29, 2026
Jain Rita · Director Grant (A) 26K
Owned 26K Trade date Jun 25, 2026 Filed date Jun 29, 2026
Jain Rita Director Grant (A) 26K 26K Jun 25, 2026 Jun 29, 2026
Neil Garry Arthur · Director Grant (A) 26K
Owned 26K Trade date Jun 25, 2026 Filed date Jun 29, 2026
Neil Garry Arthur Director Grant (A) 26K 26K Jun 25, 2026 Jun 29, 2026
Cohen Cheryl · Director Grant (A) 26K
Owned 26K Trade date Jun 25, 2026 Filed date Jun 29, 2026
Cohen Cheryl Director Grant (A) 26K 26K Jun 25, 2026 Jun 29, 2026
Brownlie Keith L. · Director Grant (A) 26K
Owned 26K Trade date Jun 25, 2026 Filed date Jun 29, 2026
Brownlie Keith L. Director Grant (A) 26K 26K Jun 25, 2026 Jun 29, 2026
15 of 25
15 of 25 Sign in to continue to older insider transactions.

Celldex Therapeutics, Inc. (CLDX) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Wellington Management Group LLP 9.2M
% of shares outstanding 13.9% Filing date Nov 8, 2024
Wellington Management Group LLP 9.2M 13.9% Nov 8, 2024
FMR LLC 6.0M
% of shares outstanding 9.1% Filing date Nov 12, 2024
FMR LLC 6.0M 9.1% Nov 12, 2024
Kynam Capital Management, LP 0
% of shares outstanding 8.8% Filing date May 15, 2026
Kynam Capital Management, LP 0 8.8% May 15, 2026
BlackRock Inc. 3.7M
% of shares outstanding 6.7% Filing date Jan 26, 2024
BlackRock Inc. 3.7M 6.7% Jan 26, 2024
FMR LLC 3.7M
% of shares outstanding 5.6% Filing date May 6, 2026
FMR LLC 3.7M 5.6% May 6, 2026
Vanguard Group Inc 3.0M
% of shares outstanding 5.6% Filing date Feb 13, 2024
Vanguard Group Inc 3.0M 5.6% Feb 13, 2024
Kynam Capital Management, LP 3.0M
% of shares outstanding 5.5% Filing date Feb 14, 2024
Kynam Capital Management, LP 3.0M 5.5% Feb 14, 2024
Vanguard Capital Management LLC 3.4M
% of shares outstanding 5.2% Filing date Apr 29, 2026
Vanguard Capital Management LLC 3.4M 5.2% Apr 29, 2026
8 of 14

Celldex Therapeutics, Inc. (CLDX) ownership FAQ

Who owns CLDX?

193 reporting institutions disclosed CLDX position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.